Product category:
Contract research
News Release from: LGC | Subject: Pharmaceutical reference substances and impurities
Edited by the Laboratorytalk Editorial
Team on 15 November 2005
LGC rebrands Mikromol reference
standards
Full product range of over 2000 impurity standards derived from more than 500 active pharmaceutical ingredients can be found in the new Pharmaceutical reference substances and impurities catalogue
LGC, Europe's leading provider of analytical and diagnostic services and reference standards, has announced its migration of the Mikromol brand, most notably the range of pharmaceutical impurity reference standards, to its own brand at the 2005 Eastern Analytical Symposium (EAS), Somerset, New Jersey, USA, 14-17 November The pharmaceutical industry is required to control impurities, or the 'unwanted' chemicals, in its formulations
This article was originally published on Laboratorytalk on 25 Sep 2003 at 8.00am (UK)
Related stories
Catalogue of reference impurities
The increasing importance of pharmaceutical impurity reference materials is reflected in the EP monographs, and is also becoming apparent in the registration of drugs
One for the pharmacists
Pharmaceutical reference substances and impurities catalogue including primary pharmaceutical standards from the US, European, and British pharmacopoeias
Since its acquisition of the German company Mikromol in 2003, LGC, the UK's designated national measurement institute (NMI) for chemistry and biochemistry, has continued to develop pharmaceutical impurity reference standards with its colleagues in Luckenwalde near Berlin.
Derek Craston, head of LGC's pharmaceutical and chemical services division, said: "Under the management of Gunter Funk and Hans Zimmermann, the Mikromol brand has established an excellent reputation in the market for the synthesis of pharmaceutical impurities.
"The decision to transfer the brand to LGC is a reflection of the progressive quality of the product, such that the stringent standards associated with a national measurement laboratory will soon be achievable.
Further reading
Pharma references and impurities catalogue
The release of the 2006 Pharmaceutical reference substances and impurities catalogue from LGC Promochem is set to make compulsory reading for the pharmaceutical industry
New FTMS for LGC
LGC selects £500k Bruker Daltonics Fourier transform instrument to expand its mass spectrometry capability for chemical and bio-molecules
"I am delighted by the changes in quality systems being instituted at Luckenwalde and by the move of our dedicated scientific team towards higher accreditation".
Morris Legge, LGC's international business development manager, said: "LGC regards EAS as an important event in the analytical calendar.
"We wanted to make this announcement at EAS in the USA, where quality standards are valued across industry, and where pharmaceutical analysis is seen as a key issue for the sector.
"LGC has gained a high standing in Europe and in India for both producing and, as LGC Promochem, distributing reference standards from leading suppliers such as Nist.
"In the USA, LGC Promochem is better becoming known for the supply of pharmaceutical impurity reference standards".
A new laboratory and production facility for pharmaceutical impurities to support the capability of LGC's German operation in Luckenwalde is planned for opening in Bangalore, India, where LGC Promochem India Private is based.
The full product range incorporating over 2000 impurity standards derived from more than 500 APIs (active pharmaceutical ingredients) can be found in LGC Promochem's new 'Pharmaceutical reference substances and impurities' catalogue.
• LGC: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
